Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Go back to Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan| Amgen Inc (NASDAQ: AMGN) | Delayed: 414.61 +8.57 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $406.04 | 52 Week High | $176.85 | |||
| Open | $408.25 | 52 Week Low | $133.64 | |||
| Day High | $415.20 | P/E | 62.44 | |||
| Day Low | $404.19 | EPS | $6.64 | |||
| Volume | 2,213,274 | |||||
| Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) | Delayed: 18.67 +0.39 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.28 | 52 Week High | $26.24 | |||
| Open | $18.59 | 52 Week Low | $18.86 | |||
| Day High | $18.77 | P/E | N/A | |||
| Day Low | $18.53 | EPS | $0.00 | |||
| Volume | 58,771 | |||||
